Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Endocrinology

Mapping the Path: Diagnosis and Understanding Test Results

At a Glance

Dyshormonogenic goiter is evaluated with venous blood tests showing persistently high TSH and typically low free T4. Once hypothyroidism is confirmed, levothyroxine should begin promptly; imaging or genetic testing can help explain the cause but should not delay treatment.

The path from an abnormal newborn screen to a suspected or confirmed diagnosis of dyshormonogenic goiter involves a series of precise steps. While the initial news can be startling, these tests are designed to give your medical team a clear “map” of your baby’s thyroid function so they can provide the most effective care [1][2].

The First Clue: The Newborn Screen

Most newborn screening programs measure Thyroid Stimulating Hormone (TSH) [3]. TSH is a signal sent from the brain to the thyroid gland, essentially “shouting” at it to work.

  • High TSH: When the thyroid isn’t making enough hormone, the brain sends more and more TSH to try to get it to respond. A high TSH on a newborn screen is an early warning sign that the thyroid might be struggling [1].
  • Next Steps: An abnormal screen is not a final diagnosis. It is a signal that your baby needs confirmatory testing—a standard blood draw from a vein—to measure the actual levels of thyroid hormone in the blood [1].

Confirming the Diagnosis

The confirmatory blood test looks at two main markers:

  1. Venous TSH: If this remains high, it confirms the brain is still signaling for more hormone [1].
  2. Free T4: This is the actual amount of active thyroid hormone circulating in your baby’s body. In cases of dyshormonogenesis, this level is typically low [1][4].

Crucially, once these blood tests confirm the thyroid is underactive, treatment with levothyroxine should start immediately. You should not wait for imaging or genetic results to begin the medication, as early treatment is the most important factor for your baby’s brain development [1][2].

Imaging: Seeing the “Factory” (If Directed by a Specialist)

After your baby has started their medication, the doctor may use imaging to see why the thyroid isn’t working, though these are specialist-directed and may not be needed in every infant [1][5].

  • Thyroid Ultrasound: This is a non-invasive scan using sound waves. It confirms that the thyroid gland is in the correct place in the neck and measures its size. In dyshormonogenesis, the gland is present and may be enlarged (a goiter) [6][7].
  • Scintigraphy (Uptake Scan): This test uses a very small, safe amount of a “tracer” (like Technetium-99m or Iodine-123) to see how the thyroid gland is functioning [6][8]. Because timing and interpretation can be affected by treatment and recent iodine exposure, this test is carefully scheduled by your endocrinologist.
    • A “bright” scan means it is successfully pulling iodine in, though there may still be a glitch in how it uses it [9].
    • If the gland doesn’t “light up,” it may have a problem with the “gate” that lets iodine in, though blocking antibodies or TSH-related factors can also cause this [10].

The Perchlorate Discharge Test

In some specialized centers, doctors may occasionally perform a perchlorate discharge test using Iodine-123. This is an uncommon and highly specialized test [6][8].

The test measures how well the thyroid “traps” iodine and “locks” it into the hormone scaffold. If the iodine is trapped but not locked in, a dose of perchlorate will cause the iodine to be “discharged” (pushed out) of the gland [8][11]. A high discharge rate suggests an organification problem, often related to several potential defects like TPO, DUOX2/DUOXA2, or SLC26A4 [6][9].

While these specialized tests provide valuable information about the “why” behind the diagnosis, they do not change the immediate “how” of treatment: ensuring your baby gets their daily thyroid hormone replacement [2].

Common questions in this guide

Does a high TSH on a newborn screen mean my baby has dyshormonogenic goiter?
Not by itself. A high TSH is an early warning that the thyroid may not be making enough hormone, so a venous blood test measuring TSH and free T4 is needed to confirm hypothyroidism and investigate the cause.
What do the confirmatory TSH and free T4 results show?
Doctors use venous TSH and free T4 to confirm whether a baby's thyroid is underactive. Persistently high TSH with a low free T4 supports hypothyroidism, while additional evaluation may be needed to identify the specific thyroid hormone production problem.
When should my baby start levothyroxine after abnormal thyroid tests?
If confirmatory blood tests show hypothyroidism, levothyroxine should start promptly. Treatment should not wait for an ultrasound, uptake scan, or genetic results because early thyroid hormone replacement supports brain development.
Why might my baby need a thyroid ultrasound or uptake scan?
An ultrasound can show whether the thyroid is in the usual neck location and measure its size; dyshormonogenic goiter may be enlarged. A scintigraphy, or uptake, scan shows how the gland takes up iodine, but it is specialist-directed and may not be needed for every infant.
What is a perchlorate discharge test used for?
This uncommon, specialized test examines whether the thyroid traps iodine but fails to use it to build thyroid hormone. A high discharge rate can suggest this type of iodine-processing problem, but it does not change the need for prompt daily levothyroxine when hypothyroidism is confirmed.
How are thyroid levels monitored after treatment starts?
Your baby's medical team will recheck thyroid hormone levels after treatment begins and at intervals as your baby grows. These results help determine whether the levothyroxine dose is keeping hormone levels in the desired range.

Get notified when new evidence is published on dyshormonogenic goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Newborn Screening Guidelines for Congenital Hypothyroidism in India: Recommendations of the Indian Society for Pediatric and Adolescent Endocrinology (ISPAE) - Part I: Screening and Confirmation of Diagnosis.

    Desai MP, Sharma R, Riaz I, et al.

    Indian journal of pediatrics 2018; (85(6)):440-447 doi:10.1007/s12098-017-2575-y.

    PMID: 29380252
  2. 2

    Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.

    van Trotsenburg P, Stoupa A, Léger J, et al.

    Thyroid : official journal of the American Thyroid Association 2021; (31(3)):387-419 doi:10.1089/thy.2020.0333.

    PMID: 33272083
  3. 3

    Newborn screening and the screening laboratory: past, present and future.

    Boelen A, Heijboer AC

    European thyroid journal 2025; (14(1)).

    PMID: 39852342
  4. 4

    Newborn screening for central congenital hypothyroidism: past, present and future.

    Garrelfs MR, Mooij CF, Boelen A, et al.

    European thyroid journal 2025; (14(1)).

    PMID: 39913280
  5. 5

    Etiological evaluation of primary congenital hypothyroidism cases.

    Bezen D, Dilek E, Torun N, Tütüncüler F

    Turk pediatri arsivi 2017; (52(2)):85-91 doi:10.5152/TurkPediatriArs.2017.3989.

    PMID: 28747839
  6. 6

    Congenital Hypothyroidism: Role of Nuclear Medicine.

    Keller-Petrot I, Leger J, Sergent-Alaoui A, de Labriolle-Vaylet C

    Seminars in nuclear medicine 2017; (47(2)):135-142 doi:10.1053/j.semnuclmed.2016.10.005.

    PMID: 28237002
  7. 7

    Iodide handling disorders (NIS, TPO, TG, IYD).

    Targovnik HM, Citterio CE, Rivolta CM

    Best practice & research. Clinical endocrinology & metabolism 2017; (31(2)):195-212 doi:10.1016/j.beem.2017.03.006.

    PMID: 28648508
  8. 8

    Imaging findings of thyroid diseases in children.

    Tsujioka Y, Yamada Y, Hasegawa T, et al.

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2025; (34(2)):89-104 doi:10.1297/cpe.2024-0082.

    PMID: 40201380
  9. 9

    Frequency of Mutations in the TPO Gene in Patients with Congenital Hypothyroidism Due to Dyshormonogenesis in Chile.

    Arteaga-Jacobo MC, Roco-Videla Á, Villota Arcos C, et al.

    Medicina (Kaunas, Lithuania) 2024; (60(7)) doi:10.3390/medicina60071145.

    PMID: 39064575
  10. 10

    Silent but Not Harmless: A Synonymous SLC5A5 Gene Variant Leading to Dyshormonogenic Congenital Hypothyroidism.

    Geysels RC, Bernal Barquero CE, Martín M, et al.

    Frontiers in endocrinology 2022; (13()):868891 doi:10.3389/fendo.2022.868891.

    PMID: 35600585
  11. 11

    The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 2: Nodular Goiter, Hypothyroidism, and Subacute Thyroiditis.

    Mariani G, Tonacchera M, Grosso M, et al.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021; (62(7)):886-895 doi:10.2967/jnumed.120.251504.

    PMID: 33579801

This page explains dyshormonogenic goiter testing in newborns for informational purposes only and does not constitute medical advice. Your baby's endocrinology team should interpret test results and guide treatment.